Author: Yong-an Ye
Title: Guideline-based Chinese herbal medicine treatment plus standard care for severe coronavirus disease 2019 (G-CHAMPS): evidence from China Document date: 2020_4_1
ID: 4as055wh_11
Snippet: Per NHC-NATCM-China guidelines, all patients received standard care, which included hemodynamic monitoring, laboratory testing, supplementary oxygen, intravenous fluids, and routine pharmaceutical medications and other medical care when deemed appropriate by on-duty physicians. Oral ribavirin/arbidole (not remdesivir) was part of the standard care in China (Appendix 1 protocol). Per the NHC-NATCM-China guidelines, patients in the CHM plus group a.....
Document: Per NHC-NATCM-China guidelines, all patients received standard care, which included hemodynamic monitoring, laboratory testing, supplementary oxygen, intravenous fluids, and routine pharmaceutical medications and other medical care when deemed appropriate by on-duty physicians. Oral ribavirin/arbidole (not remdesivir) was part of the standard care in China (Appendix 1 protocol). Per the NHC-NATCM-China guidelines, patients in the CHM plus group also received CHM within 12 hours after randomization (Appendix 1 protocol). The herbal formulas were supported by Jiangyin Tianjiang Pharmaceutical Co., Ltd. Quality of the herbs was in accordance with the 2015 Chinese All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- duty physician and medical care: 1
- hemodynamic monitoring and medical care: 1, 2
- intravenous fluid and laboratory testing: 1, 2
- intravenous fluid and medical care: 1, 2
- laboratory testing and medical care: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
Co phrase search for related documents, hyperlinks ordered by date